The global esophageal implant market size is estimated to reach USD 147.0 million in 2023. From 2023 to 2033, global esophageal implant sales are projected to soar at 6.7% CAGR. By the end of 2033, total market value is likely to exceed USD 280.2 million.
Implants used to treat various esophageal disorders such as gastroesophageal reflux disease (GERD) and esophageal strictures are referred to as esophageal implants. These include esophageal stents, artificial esophageal valves, magnetic sphincter augmentation devices, and injectable bulking agents.
Usage of esophageal implants significantly improves the quality of life in patients suffering from esophageal problems. This is due to their ability to relieve various symptoms and reduce need for medical therapies (acid pills, etc.).
The market growth is being propelled due to the rising need for surgical resection of the esophagus as a result of cancer, trauma, or birth defects.
As per the Centers for Disease Control and Prevention, around one child suffers from esophageal atresia in every 4,100 children born in the United States. This birth condition can occur on its own, although it is more commonly associated with other birth problems. Such escalating faults are important drivers fueling market expansion.
Esophageal implants have emerged as the most effective treatment for a variety of illnesses, including GERD and esophageal strictures. As a result of the increasing efficacy of these implants in therapies, the demand for esophageal implants is increasing.
Rising patient inclination towards minimally invasive procedures is another key factor that is expected to fuel esophageal implant demand globally. Subsequently, growing popularity of biodegradable stents and hybrid implants is likely to support market expansion.
Leading esophageal implant manufacturers are concentrating on developing new innovative solutions with several advantages. For instance, to treat esophageal atresia and other esophageal disorders, Biostage is developing its Cellspan esophageal implant.
These new implants can significantly improve patient outcomes by potentially simplifying surgical techniques to reduce post-operative complications, enhance quality of life, and enable regeneration of the patient’s own esophagus.
| Attributes | Key Insights |
|---|---|
| Estimated Global Esophageal Implant Market Size (2023) | USD 147.0 million |
| Projected Esophageal Implant Market Value (2033) | USD 280.2 million |
| Value-based CAGR (2023 to 2033) | 6.7% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Challenges for Companies /Manufacturers in the Esophageal Implant Industry:
Opportunities in the Esophageal Implant Industry:
Latest Trends in the Esophageal Implant Market:
According to Future Market Insights’ (FMI) latest report, global sales of esophageal implants increase at a CAGR of 5.6% from 2017 to 2022. Total market size reached USD 139.1 million in 2022.
From 2017 to 2022, the global esophageal implant industry witnessed steady growth due to the rising preference for esophageal implants for treatments.
Initially, surgery was the only option for treating tracheoesophageal fistula (TEF). Although this is still true for benign TEF and other disorders, implantation of esophageal implant is currently the preferred treatment for both malignant and benign TEF when surgery cannot be delayed.
Self-expanding metal stents (SEMS) have been the preferred stent since the mid-1990s, replacing hard plastic prostheses.
Looking ahead, the global esophageal implant industry is expected to rise at a CAGR of 6.7% from 2023 to 2033. During the forecast period, the market size is expected to reach USD 280.2 million.
Growth in the market is expected to be driven by rising cases of esophageal disorders, innovations in esophageal implants, and a strong desire for minimally invasive procedures.
Introduction of several medical innovations and rising demand for implants & therapies involving minimally invasive surgery will further boost the market.
Principal Consultant
Growing Awareness Regarding Treatment of Esophageal Disorders Fueling Demand in the United States
| Country | United States |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 105.2 million |
| CAGR % from 2023 to End of Forecast (2033) | 7.3% |
As per Future Market Insights (FMI), the United States esophageal implant industry is expected to reach a valuation of USD 105.2 million by 2033. From 2023 to 2033, esophageal implant sales in the country are likely to surge at 7.3% CAGR.
The United States esophageal implant industry is predicted to expand due to the country's high knowledge of esophageal disease management and treatment. This encourages key firms to develop and launch new products, which will ultimately help them expand their market.
Favorable legislation, presence of significant esophageal stent suppliers, new product releases, and the use of cutting-edge technology are other factors boosting the United States market.
Similarly, rising cases of GERD is likely to elevate esophageal implant demand during the projection period.
Prevalence of Esophageal Cancers to Retain High Demand for Esophageal Stents the United Kingdom
| Country | The United Kingdom |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 14.11 million |
| CAGR % from 2023 to End of Forecast (2033) | 5.6% |
The United Kingdom esophageal implant industry is forecast to attain a valuation of USD 14.11 million by 2033. Total esophageal implant demand in China is projected to rise at 5.6% CAGR during the forecast period.
Growth in the market is expected to be driven by rising prevalence of esophageal cancer in the country.
Esophageal stents are eventually employed by doctors to open up a blockage caused by cancer. This aids in the relief of symptoms produced by the obstruction.
Increasing Cases of Dysphagia to Bolster Esophageal Implant Sales in China
| Country | China |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 21.34 million |
| CAGR % from 2023 to End of Forecast (2033) | 8.6% |
As per Future Market Insights (FMI), esophageal implant sales in China are anticipated to soar at 8.6% CAGR through 2033. Total market valuation in China at the end of 2033 is expected to reach USD 21.34 million.
The esophageal implant industry in China is likely to expand prominently due to the high prevalence of dysphagia.
Dysphagia is becoming more common in China, especially among the elderly and those who have had strokes. To treat this medical condition, esophageal implants such as stents are being used.
Rising Instances of Barrett’s Esophagus Disease to Elevate Esophageal Implant Demand in Japan
| Country | Japan |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 4.4 million |
| CAGR % from 2023 to End of Forecast (2033) | 7.5% |
Japan esophageal implant industry is estimated to reach a valuation of USD 4.4 million by 2033. It is likely to thrive at a CAGR of 7.5% during 2023 to 2033. The market in Japan is predicted to expand because of the increasing geriatric population.
Japan has one of the world's leading shares of geriatric population. The risk of esophageal disorders such as esophageal cancer, gastroesophageal reflux disease (GERD), and Barrett's esophagus increase with age. These diseases often necessitate surgery and the use of esophageal implants.
Increasing Government Support for Development of Medical Devices to Boost Korea Market
| Country | South Korea |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 0.7 million |
| CAGR % from 2023 to End of Forecast (2033) | 6.9% |
The Korea esophageal implant industry is poised to exhibit a CAGR of 6.9% during the projection period. Total market valuation in Korea is projected to reach USD 0.7 million by 2033.
The market in South Korea is forecast to witness robust growth due to favorable government support for product development. Through different initiatives and funding support, the South Korean government has aggressively fostered the development of the medical device industry.
Financial incentives, research grants, and tax breaks are available to enterprises engaged in medical device research and development. Because of the government's commitment to supporting innovation in the healthcare sector, both domestic and foreign enterprises have invested in medical device development.
Esophageal Stents to Create the Most Profitable Opportunities for Manufacturers
According to Future Market Insights (FMI), esophageal stents segment is expected to dominate the global market. It is likely to thrive at a CAGR of 6.0% from 2023 to 2033, making it a key revenue-generation segment.
Growth of the target segment is driven by rising usage of esophageal stents for treating various conditions due to their less postoperative difficulties.
Esophageal stents have become key tools for palliative treatment of inoperable esophageal malignancies. They are mostly placed in the esophagus to keep blocked areas open. These stents can also be used to treat conditions such as esophageal fistulas, strictures, leaks, and perforations.
Development of advanced stents by manufacturers to lower the operative risks in patients will further boost the target segment.
Leading esophageal implant manufacturers are introducing novel products that are safe and easy to use. For instance, BONASTENT is an esophageal stent product. It has an anatomically adjustable nitinol hook and cross-wire construction. Its outspread and returning forces are appropriate for excellent conformability.
Growing popularity of bioabsorbable stents is another factor that is expected to boost growth of the target segment.
Gastroesophageal Reflux Disease (GERD) Treatment Application to Lead the Market
Application in treatment of gastroesophageal reflux disease (GERD) is expected to dominate the esophageal implant industry, exhibiting a CAGR of 7.4% from 2023 to 2033. This is due to rising prevalence of GERD coupled with increasing usage of esophageal implants for treating this medical condition.
Numerous studies have found that one of the main causes of GERD disease is obesity or excess belly fat. Over 20% of persons in the United States suffer from GERD as a result of being overweight or obese. This in turn is likely to elevate esophageal implant demand during the assessment period.
Hospitals Remain the Leading End User of Esophageal Implants
As per the latest report, hospitals will remain the leading end-users of esophageal implants. The target segment is likely to progress at a CAGR of 7.1% from 2023 to 2033. This is due to the presence of high skilled professionals in the hospitals and rising patient inclination on getting treatments in hospitals.
Hospitals continue to be the most widely used setting for doing minimally invasive procedures for gastrointestinal diseases. The existence of cutting-edge infrastructure and qualified medical personnel is what drives demand for esophageal implants in hospitals.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The esophageal implant industry is highly competitive due to large presence of regional and local players. In such a scenario, companies must adopt effective strategies to stay ahead of the competition.
Key Strategies Adopted by the Players:
Product Innovation
Companies are investing rigorously in research and development to introduce new products with enhanced features. Product innovation enables manufacturers to differentiate themselves from their competitors and meet the evolving needs of customers.
Strategic Partnerships and Collaborations
Key players in the industry often form strategic alliances, collaborations, and partnerships with other companies to leverage their strengths and expand their reach in the market.
Expansion into Emerging Markets
The esophageal implant industry is witnessing significant growth in emerging markets such as China and India. Key esophageal implant manufacturers are expanding their presence in these markets by establishing local manufacturing facilities and strengthening their distribution networks.
Mergers and Acquisitions
Key esophageal implant companies are also adopting mergers and acquisitions to strengthen their market position, expand their portfolio, and gain access to new markets.
Key Players in the Esophageal Implant Industry:
Key Developments in the Esophageal Implant Industry:
| Attribute | Details |
|---|---|
| Estimated Market Size (2023) | USD 147.0 million |
| Projected Market Size (2033) | USD 280.2 million |
| Anticipated Growth Rate (2023 to 2033) | 6.7% CAGR |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | USD million for Value and MT for Volume |
| Key Regions Covered | North America; Latin America; Europe; Asia Pacific; and Middle East and Africa |
| Key Countries Covered | United States, Canada, Mexico, Brazil, Germany, Italy, France, United Kingdom, Spain, BENELUX, Russia, China, Japan, South Korea, India, ASEAN, Australia and New Zealand, Türkiye, South Africa, GCC Countries, Others. |
| Key Segments Covered | Product, Application, End User, and Region |
| Key Companies Profiled | Boston Scientific; Medtronic; Cook Medical; Taewoong Medical; Micro-Tech (Nanjing) Co., Ltd.; Ella-CS; M.I. Tech; Merit Medical; Xlumena Inc.; Olympus Corporation; Johnson & Johnson; Apollo Endosurgery, Inc.; EndoStim; NDO Surgical, Inc; Mederi Therapeutics; Becton Dickenson & Company; Baxter International (Synovis Surgical Innovations) |
The esophageal implant industry is highly competitive due to large presence of regional and local players. In such a scenario, companies must adopt effective strategies to stay ahead of the competition.
Product Innovation
Companies are investing rigorously in research and development to introduce new products with enhanced features. Product innovation enables manufacturers to differentiate themselves from their competitors and meet the evolving needs of customers.
Strategic Partnerships and Collaborations
Key players in the industry often form strategic alliances, collaborations, and partnerships with other companies to leverage their strengths and expand their reach in the market.
Expansion into Emerging Markets
The esophageal implant industry is witnessing significant growth in emerging markets such as China and India. Key esophageal implant manufacturers are expanding their presence in these markets by establishing local manufacturing facilities and strengthening their distribution networks.
Mergers and Acquisitions
Key esophageal implant companies are also adopting mergers and acquisitions to strengthen their market position, expand their portfolio, and gain access to new markets.
The overall market value could be nearly USD 147 million in 2023.
The global market is projected to retain its growth rate at 6.7% per year through 2033.
Boston, Medtronic, and Cook Medical are the leading suppliers of Esophageal implants.
GERD treatment is the leading segment which is anticipated to follow 7.4% CAGR till 2033.
The United States to retain its top position with 7.3% CAGR through 2033.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Value-Added Insights 5. Market Background 6. Global Market Volume (in Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033 7. Global Market - Pricing Analysis 8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product 8.1. Esophageal Stents 8.1.1. Self-Expandable Metal Stents (SEMS) 8.1.2. Self-Expandable Plastic Stents (SEPS) 8.2. Magnetic Sphincter Augmentation (MSA) Devices 8.3. Injectable Bulking Agents 8.4. Artificial Esophageal Valves 8.4.1. Endoscopic Esophageal Valves 8.4.2. Prosthetic Esophageal Valves 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application 9.1. Gastroesophageal Reflux Disease (GERD) 9.2. Esophageal Strictures 9.3. Esophageal Fistulas 9.4. Esophageal Defects 9.5. Weakened Esophageal Sphincters 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 10.1. Hospitals 10.2. Ambulatory Surgical Centers 10.3. Specialty Clinics 10.4. Academic & Research Institutions 11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region 11.1. North America 11.2. Latin America 11.3. Europe 11.4. South Asia 11.5. East Asia 11.6. Oceania 11.7. Middle East and Africa 12. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 13. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 14. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 19. Market Structure Analysis 20. Competition Analysis 20.1. Boston Scientific 20.2. Medtronic 20.3. Cook Medical 20.4. Taewoong Medical 20.5. Micro-Tech (Nanjing) Co., Ltd. 20.6. Ella-CS 20.7. M.I. Tech 20.8. Merit Medical 20.9. Xlumena Inc. 20.10. Olympus Corporation 20.11. Johnson & Johnson 20.12. Apollo Endosurgery, Inc. 20.13. EndoStim 20.14. NDO Surgical, Inc 20.15. Mederi Therapeutics 20.16. Becton Dickenson & Company 20.17. Baxter International (Synovis Surgical Innovations) 21. Assumptions and Acronyms Used 22. Research Methodology
Explore Healthcare Insights
View Reports
Esophageal Implant Market
